Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Dobutamine 💬
(Dobutamine (USAN/INN))		[1] Dobutamine (Dobutaminum)[2] Dobutamin; Dobutamine[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 57, 58, 215 💬
2 Dobutamine hydrochloride 💬
(Dobutamine hydrochloride (JP18/USP), DOBUTAMINE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE IN DEXTROSE, DOBUTAMINE IN DEXTROSE)		[1] Dobutamine (Dobutaminum)[2] Dobutamin; Dobutamine[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 57, 58, 215 💬
3 Dobutamine tartrate 💬
(Dobutamine tartrate (USAN))		[1] Dobutamine (Dobutaminum)[2] Dobutamin; Dobutamine[1] ADRB1 💬 [13] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[3] 57, 58, 215 💬